Ftse Mib
34.657,35
0,93%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
61.395,72
0,98%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX OncoCyte Corporation (OCX) OncoCyte Corporation (OCX) Notizie

OCX

OncoCyte (OCX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:OCX
DataOraFonteTitoloSimboloCompagnia
13/06/202322:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:OCXOncoCyte Corporation
09/06/202312:02Edgar (US Regulatory)Current Report Filing (8-k)AMEX:OCXOncoCyte Corporation
19/05/202322:52Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:OCXOncoCyte Corporation
01/05/202322:49Edgar (US Regulatory)Amended Annual Report (10-k/a)AMEX:OCXOncoCyte Corporation
19/04/202300:50Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)AMEX:OCXOncoCyte Corporation
14/04/202322:32Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:OCXOncoCyte Corporation
12/04/202322:55Edgar (US Regulatory)Annual Report (10-k)AMEX:OCXOncoCyte Corporation
07/04/202316:39Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:OCXOncoCyte Corporation
03/04/202312:02Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)AMEX:OCXOncoCyte Corporation
14/02/202317:34Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:OCXOncoCyte Corporation
10/11/202222:50Edgar (US Regulatory)Quarterly Report (10-q)AMEX:OCXOncoCyte Corporation
22/09/202223:39Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:OCXOncoCyte Corporation
26/05/202222:15Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:OCXOncoCyte Corporation
18/04/202215:15Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:OCXOncoCyte Corporation
29/07/202122:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:OCXOncoCyte Corporation
07/07/202122:06Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:OCXOncoCyte Corporation
15/06/202114:03Business WireEchelonDx & Oncocyte Announce Collaboration to Create Seamless Informatics Software to Scale Proprietary Clinical Test Offeri...AMEX:OCXOncoCyte Corporation
09/06/202112:04Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:OCXOncoCyte Corporation
01/06/202122:26Edgar (US Regulatory)Amended Current Report Filing (8-k/a)AMEX:OCXOncoCyte Corporation
28/05/202123:07Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:OCXOncoCyte Corporation
21/05/202122:11Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:OCXOncoCyte Corporation
08/03/202122:17Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:OCXOncoCyte Corporation
05/03/202119:44Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)AMEX:OCXOncoCyte Corporation
05/03/202114:01Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeeme...AMEX:OCXOncoCyte Corporation
01/03/202122:34Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)AMEX:OCXOncoCyte Corporation
05/02/202112:07Edgar (US Regulatory)Registration of Additional Securities (up to 20%) (s-3mef)AMEX:OCXOncoCyte Corporation
18/05/202012:07Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)AMEX:OCXOncoCyte Corporation
18/03/202020:15Edgar (US Regulatory)Unknown (sec Staff)AMEX:OCXOncoCyte Corporation
14/02/201914:00GlobeNewswire Inc.BioTime Provides Business Update Including Information on AgeX, OncoCyte and AsteriasAMEX:OCXOncoCyte Corporation
14/08/201822:10GlobeNewswire Inc.OncoCyte Reports Second Quarter 2018 Financial Results and Positive Corporate DevelopmentsAMEX:OCXOncoCyte Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:OCX

La tua Cronologia

BIT
P1USI4
NLBNPIT1USI4 20991231 6....
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network